Showing results (41-50 of 80) with videos related to
Sort By:
Pageof 8
Nihon Geka Gakkai Zasshi|January 1, 1985
[An in vitro sensitivity assay of anti-cancer agents by measuring the inhibition rate of DNA synthesis (3H-thymidine uptake) of cancer cells--clinical study]Y Nio, T Inamoto, K Ohgaki, et al.Journal of Surgical Oncology|May 14, 1998
Cyclophosphamide given after active specific immunization augments antitumor immunity by modulation of Th1 commitment of CD4+ T cellsL Li, T Okino, T Sugie, et al.Journal of Surgical Oncology|May 1, 1994
The synergistic antitumor effect of recombinant interleukin-1 and low-dose of cyclophosphamide in tumor-bearing miceT Harada, N Kan, Y Ichinose, et al.Cancer|August 1, 1995
Papillary serous carcinoma of the peritoneum in women. A clinicopathologic and immunohistochemical studyJ Zhou, Y Iwasa, I Konishi, et al.Clinical Nutrition (Edinburgh, Scotland)|June 12, 2002
Measured versus estimated energy expenditure in mechanically ventilated critically ill patientsC-H Cheng, C-H Chen, Y Wong, et al.Biotherapy (Dordrecht, Netherlands)|January 1, 1990
Comparison between crude interleukin-2 and recombinant interleukin-2 in maintaining killing activity of cultured lymphocytesM Nakanishi, N Kan, T Okino, et al.Journal of Surgical Oncology|June 1, 1996
A new model of active specific immunotherapy using interleukin-1 and sonicated tumor supernatant in murine tumor systemY Moriguchi, N Kan, T Okino, et al.Biotherapy (Dordrecht, Netherlands)|January 1, 1993
The therapeutic effect of OK-432-combined adoptive immunotherapy against liver metastases from gastric or colorectal cancersK Satoh, N Kan, T Okino, et al.Surgery Today|January 1, 1994
The induction of specific antitumor immunity by in vivo treatment with interleukin-1 and sonicated tumor extract in a murine modelT Harada, N Kan, T Okino, et al.Gan to Kagaku Ryoho. Cancer & Chemotherapy|August 1, 1993
[Transarterial immuno-chemotherapy including adoptive transfer of autologous cultured lymphocytes for stage IV breast cancer patients with locally-advanced tumor]N Kan, T Harada, H Kodama, et al.Pageof 8